Pardis Yousefi Talouki

Dr. Pardis Yousefi Talouki

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2022 in International Journal of Polymeric Materials and Polymeric Biomaterials
Verified
Journal Article
Closed access
PTPardis Yousefi Talouki
Pardis Yousefi Talouki
RTReyhaneh Tamimi
Reyhaneh Tamimi
SBSoheila Zamanlui Benisi
Soheila Zamanlui Benisi
VGVahabodin Goodarzi
Vahabodin Goodarzi
SSShahrokh Shojaei
Shahrokh Shojaei
HSHamid Reza Samadikhah
Hamid Reza Samadikhah
Nowadays, elastomeric materials with a wide range of properties as a valuable strategy play a wide role in meeting the needs of reconstructive medicine and tissue engineering. In the last two decades, poly glycerol sebacate has shown great potential in the medical industry, especially in the engineering of soft tissues. Although PGS has an elastomeric and biocompatibility nature, it has poor mechanical properties. To overcome this problem, different composites and nanocomposites with hydroxyapatite, carbon nanotubes, graphene, etc. can be used. In this study, we review the properties of PGS-based composite and nanocomposites, as well as their applications in tissue engineering. Graphical Abstract

29 September 2025 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
PTPardis Yousefi Talouki
Pardis Yousefi Talouki
RTReyhaneh Tamimi
Reyhaneh Tamimi
SRSomayeh Gholami Rudi
Somayeh Gholami Rudi
Articular cartilage’s avascular and aneural nature severely limits its intrinsic regenerative capacity, making injuries and degenerative diseases like osteoarthritis a significant clinical challenge. This review comprehensively examines the paradigm shift towards regenerative medicine strategies, focusing on the integration of the natural polyphenol curcumin into advanced cartilage tissue engineering. While curcumin possesses potent multi-modal therapeutic properties—including anti-inflammatory, antioxidant, anti-catabolic, and chondroprotective effects—its clinical translation is hindered by poor bioavailability and rapid metabolism. We explore innovative biomaterial-based solutions to these limitations, detailing the development of sophisticated DDSs such as nanoparticles, hydrogels (e.g., chitosan, gelatin methacrylate), and synthetic scaffolds (e.g., PCL, PLGA) that enable targeted, sustained release. The review critically analyzes the transition from conventional surgical techniques to emerging therapies like MSC-based treatments, gene therapy, and 3D-bioprinted constructs. Furthermore, we synthesize compelling clinical evidence demonstrating that bioavailable curcumin formulations (e.g., Meriva®, Theracurmin®) significantly improve pain, stiffness, and functional scores in OA and RA patients. By bridging cutting-edge biomaterial science with the ancient therapeutic wisdom of curcumin, this review highlights a promising frontier in restoring joint integrity and offers a critical roadmap for future research in combinatorial regenerative approaches. Graphical abstract

21 February 2026 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
PTPardis Yousefi Talouki
Pardis Yousefi Talouki
RTReyhaneh Tamimi
Reyhaneh Tamimi
MMMoein Mahmoodi
Moein Mahmoodi

19 February 2026 in Tissue and Cell
Verified
Journal Article
Closed access
PTPardis Yousefi Talouki
Pardis Yousefi Talouki
RTReyhaneh Tamimi
Reyhaneh Tamimi
MMMoein Mahmoodi
Moein Mahmoodi